Longevity Angitia Bio lands $130m to advance human trials of musculoskeletal health drugsBy adminFebruary 8, 20260 Company’s osteoporosis program completes enrollment in Phase 2 trial focused on treating the disease in postmenopausal women. US biotech Angitia…
Probiotics Managing Musculoskeletal Pain in MS: Causes, Symptoms, and TreatmentsBy adminNovember 27, 20250 Causes of Musculoskeletal Pain in MSMusculoskeletal pain in MS has many possible causes, all of which stem from the way…
Longevity Startup emerges with $8m to combat musculoskeletal diseasesBy adminNovember 19, 20250 Skeletalis initially targets osteoporosis with bone-targeted drug delivery designed to minimize systemic exposure. Precision medicine startup Skeletalis has secured an…
